Brief: S&P Says Sun Pharmaceutical Industries Assigned Preliminary 'BBB+' Rating With Stable Outlook
BRIEF-S&P Says Sun Pharmaceutical Industries Assigned Preliminary 'BBB+' Rating With Stable Outlook Sept 8 (Reuters) -
S&P: SUN PHARMACEUTICAL INDUSTRIES ASSIGNED PRELIMINARY 'BBB+' RATING WITH STABLE OUTLOOK
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses